Cargando…

SARS-CoV-2 Risk Management in Clinical Psychiatry: A Few Considerations on How to Deal With an Unrivaled Threat

The pandemic spread of the corona virus SARS-CoV-2 has even-handedly shattered national and international health systems and economies almost in an instant. As numbers of infections and COVID-19–related deaths rise from day to day, fears and uncertainties on how to deal with this unknown threat are...

Descripción completa

Detalles Bibliográficos
Autores principales: Kreuzer, Peter M., Baghai, Thomas C., Rupprecht, Rainer, Wittmann, Markus, Steffling, Dagmar, Ziereis, Michael, Zowe, Marc, Hausner, Helmut, Langguth, Berthold
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300317/
https://www.ncbi.nlm.nih.gov/pubmed/32595541
http://dx.doi.org/10.3389/fpsyt.2020.00550
_version_ 1783547563769593856
author Kreuzer, Peter M.
Baghai, Thomas C.
Rupprecht, Rainer
Wittmann, Markus
Steffling, Dagmar
Ziereis, Michael
Zowe, Marc
Hausner, Helmut
Langguth, Berthold
author_facet Kreuzer, Peter M.
Baghai, Thomas C.
Rupprecht, Rainer
Wittmann, Markus
Steffling, Dagmar
Ziereis, Michael
Zowe, Marc
Hausner, Helmut
Langguth, Berthold
author_sort Kreuzer, Peter M.
collection PubMed
description The pandemic spread of the corona virus SARS-CoV-2 has even-handedly shattered national and international health systems and economies almost in an instant. As numbers of infections and COVID-19–related deaths rise from day to day, fears and uncertainties on how to deal with this unknown threat are extremely present both for individuals and societies as a whole. In this manuscript, we aim to exemplarily describe the bullet points concerning (a) the internal risk management, (b) the organizational and structural changes, and (c) the communicational strategies applied in a Psychiatric University Hospital in the Southern part of Germany. The authors are well aware about the fact that almost none of these considerations may be considered as evidence-based at the moment. However, the authors trust that these reflections and experiences may be useful as an orientation for similar risk constellations in other afflicted countries due to the temporal delay of the pandemic course.
format Online
Article
Text
id pubmed-7300317
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-73003172020-06-26 SARS-CoV-2 Risk Management in Clinical Psychiatry: A Few Considerations on How to Deal With an Unrivaled Threat Kreuzer, Peter M. Baghai, Thomas C. Rupprecht, Rainer Wittmann, Markus Steffling, Dagmar Ziereis, Michael Zowe, Marc Hausner, Helmut Langguth, Berthold Front Psychiatry Psychiatry The pandemic spread of the corona virus SARS-CoV-2 has even-handedly shattered national and international health systems and economies almost in an instant. As numbers of infections and COVID-19–related deaths rise from day to day, fears and uncertainties on how to deal with this unknown threat are extremely present both for individuals and societies as a whole. In this manuscript, we aim to exemplarily describe the bullet points concerning (a) the internal risk management, (b) the organizational and structural changes, and (c) the communicational strategies applied in a Psychiatric University Hospital in the Southern part of Germany. The authors are well aware about the fact that almost none of these considerations may be considered as evidence-based at the moment. However, the authors trust that these reflections and experiences may be useful as an orientation for similar risk constellations in other afflicted countries due to the temporal delay of the pandemic course. Frontiers Media S.A. 2020-06-11 /pmc/articles/PMC7300317/ /pubmed/32595541 http://dx.doi.org/10.3389/fpsyt.2020.00550 Text en Copyright © 2020 Kreuzer, Baghai, Rupprecht, Wittmann, Steffling, Ziereis, Zowe, Hausner and Langguth http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychiatry
Kreuzer, Peter M.
Baghai, Thomas C.
Rupprecht, Rainer
Wittmann, Markus
Steffling, Dagmar
Ziereis, Michael
Zowe, Marc
Hausner, Helmut
Langguth, Berthold
SARS-CoV-2 Risk Management in Clinical Psychiatry: A Few Considerations on How to Deal With an Unrivaled Threat
title SARS-CoV-2 Risk Management in Clinical Psychiatry: A Few Considerations on How to Deal With an Unrivaled Threat
title_full SARS-CoV-2 Risk Management in Clinical Psychiatry: A Few Considerations on How to Deal With an Unrivaled Threat
title_fullStr SARS-CoV-2 Risk Management in Clinical Psychiatry: A Few Considerations on How to Deal With an Unrivaled Threat
title_full_unstemmed SARS-CoV-2 Risk Management in Clinical Psychiatry: A Few Considerations on How to Deal With an Unrivaled Threat
title_short SARS-CoV-2 Risk Management in Clinical Psychiatry: A Few Considerations on How to Deal With an Unrivaled Threat
title_sort sars-cov-2 risk management in clinical psychiatry: a few considerations on how to deal with an unrivaled threat
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300317/
https://www.ncbi.nlm.nih.gov/pubmed/32595541
http://dx.doi.org/10.3389/fpsyt.2020.00550
work_keys_str_mv AT kreuzerpeterm sarscov2riskmanagementinclinicalpsychiatryafewconsiderationsonhowtodealwithanunrivaledthreat
AT baghaithomasc sarscov2riskmanagementinclinicalpsychiatryafewconsiderationsonhowtodealwithanunrivaledthreat
AT rupprechtrainer sarscov2riskmanagementinclinicalpsychiatryafewconsiderationsonhowtodealwithanunrivaledthreat
AT wittmannmarkus sarscov2riskmanagementinclinicalpsychiatryafewconsiderationsonhowtodealwithanunrivaledthreat
AT stefflingdagmar sarscov2riskmanagementinclinicalpsychiatryafewconsiderationsonhowtodealwithanunrivaledthreat
AT ziereismichael sarscov2riskmanagementinclinicalpsychiatryafewconsiderationsonhowtodealwithanunrivaledthreat
AT zowemarc sarscov2riskmanagementinclinicalpsychiatryafewconsiderationsonhowtodealwithanunrivaledthreat
AT hausnerhelmut sarscov2riskmanagementinclinicalpsychiatryafewconsiderationsonhowtodealwithanunrivaledthreat
AT langguthberthold sarscov2riskmanagementinclinicalpsychiatryafewconsiderationsonhowtodealwithanunrivaledthreat